IRESSA 250
Generic Name: gefitinib
Pill imprint IRESSA 250 has been identified as Iressa 250 mg.
Iressa is used in the treatment of non-small cell lung cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy.
Iressa 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Iressa Images
- Generic Name:
- gefitinib
- Imprint:
-
IRESSA 250
- Strength:
- 250 mg
- Color:
- Brown
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose monohydrate
microcrystalline cellulose
croscarmellose sodium
povidone
sodium lauryl sulfate
magnesium stearate
hypromellose
polyethylene glycol 300
titanium dioxide
ferric oxide red
ferric oxide yellow
- Drug Class:
- EGFR inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- AstraZeneca Pharmaceuticals
- National Drug Code (NDC):
- 00310-0482
Advertisement
More Iressa resources
Search Again
